Fusion Pharmaceuticals Inc

Apr 18 5:55am ET Fusion Pharmaceuticals management to meet with Oppenheimer by TipRanks Apr 17 4:55am ET Fusion Pharmaceuticals management to meet with Oppenheimer by TipRanks Apr 16 7:17am ET Fusion Pharmaceuticals downgraded to Hold from Buy at TD Cowen by TipRanks Apr 15 7:51am ET Fusion Pharmaceuticals management to meet with Oppenheimer by TipRanks Apr 12 1:37am ET Fusion Pharmaceuticals: Market Perform Rating Amid Acquisition and Promising Prostate Cancer Treatment Data by TipRanks Mar 28 2:49pm ET What Fusion Pharmaceuticals (NASDAQ:FUSN) Acquisition Means for Investors by TipRanks Mar 21 8:46am ET Largest borrow rate increases among liquid names by TipRanks Mar 20 5:47pm ET Fusion Pharmaceuticals Accelerates Oncology Pipeline by TipRanks Mar 20 4:11pm ET Fusion Pharmaceuticals reports Q4 EPS (39c), consensus (34c) by TipRanks Mar 20 9:57am ET Wells Fargo downgraded, Best Buy upgraded: Wall Street’s top analyst calls by TipRanks Mar 20 8:21am ET Fusion Pharmaceuticals downgraded to Neutral from Buy at B. Riley by TipRanks Mar 20 8:19am ET Fusion Pharmaceuticals downgraded to Market Perform from Strong Buy at Raymond James by TipRanks Mar 20 8:06am ET Fusion Pharmaceuticals: Hold Rating Justified Amid Acquisition and Radiopharmaceutical Market Dynamics by TipRanks Mar 20 6:54am ET Fusion downgraded to Sector Perform from Outperform at RBC Capital by TipRanks Mar 19 4:25pm ET Fusion Pharmaceuticals (FUSN) was downgraded to a Hold Rating at JonesTrading by TipRanks Mar 19 4:20pm ET Fusion Pharmaceuticals downgraded to Hold from Buy at JonesResearch by TipRanks Mar 19 2:44pm ET Fusion Pharmaceuticals downgraded to Equal Weight from Overweight at Morgan Stanley by TipRanks Mar 19 12:55pm ET Actinium Pharmaceuticals price target raised to $30 from $20 at Maxim by TipRanks Mar 19 12:05pm ET Fusion Pharmaceuticals: Hold Rating Affirmed Post-AstraZeneca Acquisition Announcement by TipRanks Mar 19 11:52am ET Fusion Pharmaceuticals downgraded to Hold from Buy at Truist by TipRanks Mar 19 11:23am ET Actinium positioned for takeout after Fusion deal, says H.C. Wainwright by TipRanks Mar 19 10:49am ET Fusion Pharmaceuticals downgraded to Market Perform at William Blair by TipRanks Mar 19 10:15am ET Fusion Pharmaceuticals: Hold Rating Amid AstraZeneca Acquisition and Radiopharmaceutical Prospects by TipRanks Mar 19 10:12am ET Fusion Pharmaceuticals downgraded to Hold from Buy at Brookline by TipRanks Mar 19 10:10am ET Fusion Pharmaceuticals downgraded to Market Perform from Strong Buy at Raymond James by TipRanks Mar 19 10:06am ET Fusion Pharmaceuticals downgraded to Hold from Buy at Jefferies by TipRanks Mar 19 9:53am ET Snowflake, MongoDB downgraded to Sell: Wall Street’s top analyst calls by TipRanks Mar 19 8:53am ET Fusion Pharmaceuticals downgraded to Neutral from Outperform at Wedbush by TipRanks Mar 19 6:33am ET Fusion Pharmaceuticals’ Acquisition and Future Focus Shift by TipRanks Mar 19 6:30am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Fusion Pharmaceuticals (FUSN), Caribou Biosciences (CRBU) and Neurogene (NGNE) by TipRanks Mar 19 6:08am ET Fusion Pharmaceuticals downgraded to Market Perform from Outperform at Leerink by TipRanks